Drug Chatter -- Tracking biopharma stock chatter

Profile for BioMarin Pharmaceutical Inc. (BMRN)

« Back to company index

BMRN Chatter Timeline

Stock Ticker for BMRN

Most Active Tweeters for BMRN

UserTweets
@investpro2000 17
@WKRBNews 12
@chaffeybreeze 8
@biotech_sector 8
@biopharmacaster 7

Recent Tweets for BMRN

Shaylan_FlyTheW @Shaylan_FlyTheW
RT @RareDR: PKU News: BioMarin Submits Peg-Pal Application to the FDA. $BMRN #FDA #PKU Read more at: https://t.co/Lj0Nmi2KvK https://t.co/…
July 19th 2017, 8:07pm
BioPharmaDive @BioPharmaDive
A long-standing patent battle between $SRPT and $BMRN looks as though it's coming to a close https://t.co/wl1famoEgo
July 19th 2017, 6:07pm
Stock_Truth @Stock_Truth
$SRPT Question 2: $BMRN license agreement Gives us broad freedom to market & patent across globe. Allows focus & removes uncertainty
July 19th 2017, 5:07pm
pnani456 @pnani456
$SRPT - $BMRN royalties already figured in the COG hence no change, growth + good cost management + good cash position
July 19th 2017, 4:07pm
TickerReport @TickerReport
BioMarin Pharmaceutical’s $BMRN “Buy” Rating Reaffirmed at Leerink Swann https://t.co/DMAPaVbOXA
July 19th 2017, 1:07pm
emq_news @emq_news
BioMarin Pharmaceutical’s $BMRN “Buy” Rating Reaffirmed at Leerink Swann https://t.co/ONn2o8OZYS
July 19th 2017, 1:07pm
intercooleronli @intercooleronli
BioMarin Pharmaceutical Inc. $BMRN Rating Lowered to Hold at Zacks Investment Research https://t.co/J6rUafi51f
July 19th 2017, 12:07pm
perrycarter @perrycarter
$prtk and $bmrn holders selling the (good) news. Proof that markets aren't efficient.
July 19th 2017, 12:07pm
realJacobBell @realJacobBell
$SRPT, $BMRN iron out Exondys 51 patent terms https://t.co/KQfjG3Ipga
July 19th 2017, 12:07pm
BioPharmaDive @BioPharmaDive
$SRPT, $BMRN iron out Exondys 51 patent terms https://t.co/wl1famGf7W
July 19th 2017, 12:07pm
RatingsNetwork @RatingsNetwork
BioMarin Pharmaceutical downgraded by Zacks Investment Research to hold. https://t.co/HIaT6SlCbb $BMRN #BMRN
July 19th 2017, 11:07am
dakotafinancial @dakotafinancial
BioMarin Pharmaceutical Inc. $BMRN Rating Increased to Strong-Buy at Zacks Investment Research https://t.co/uy8xZswwUS
July 19th 2017, 9:07am
XsleepftLearner @XsleepftLearner
$srpt Ingram hits the ground running.Didn't try nickle dime $bmrn.Pulled up more line.Already making a difference. https://t.co/ct7FTy1ZgO
July 19th 2017, 9:07am
biopharmacaster @biopharmacaster
@GraniteGrab meaning they just wrote a check to $bmrn, then realized they didn't have enough cash in the bank, so t… https://t.co/YpphTRnTZZ
July 19th 2017, 8:07am
biopharmacaster @biopharmacaster
$srpt a little ironic how they write a check to $bmrn then a credit facility
July 19th 2017, 7:07am
dailypoliticaln @dailypoliticaln
BioMarin Pharmaceutical Inc. $BMRN Rating Increased to Strong-Buy at Zacks Investment Research https://t.co/77oMVuinBM
July 19th 2017, 2:07am
midetimes @midetimes
BioMarin Pharmaceutical Inc. $BMRN Rating Increased to Strong-Buy at Zacks Investment Research https://t.co/0oBl8uZ8nd
July 19th 2017, 2:07am
WatchlistN @WatchlistN
ValuEngine Downgrades BioMarin Pharmaceutical Inc. $BMRN to Sell https://t.co/MiXzABEt7T
July 19th 2017, 2:07am
SPNewsAnalysis @SPNewsAnalysis
BioMarin Pharmaceutical Inc. $BMRN Upgraded by Zacks Investment Research to “Strong-Buy” https://t.co/UIbauGuc5b
July 19th 2017, 1:07am
WKRBNews @WKRBNews
BioMarin Pharmaceutical Inc. $BMRN Upgraded by Zacks Investment Research to “Strong-Buy” https://t.co/Y5MBxHcy5S
July 19th 2017, 12:07am
WKRBNews @WKRBNews
BioMarin Pharmaceutical Inc. $BMRN Upgraded by Zacks Investment Research to “Strong-Buy” https://t.co/DsLkvXiM7i
July 19th 2017, 12:07am
TheMarketsDaily @TheMarketsDaily
BioMarin Pharmaceutical Inc. $BMRN Downgraded to Sell at ValuEngine https://t.co/6l7KGWL3pG
July 19th 2017, 12:07am
WKRBNews @WKRBNews
BioMarin Pharmaceutical Inc. $BMRN Downgraded to Sell at ValuEngine https://t.co/vm4sp9oOCF
July 19th 2017, 12:07am
WKRBNews @WKRBNews
BioMarin Pharmaceutical Inc. $BMRN Downgraded to Sell at ValuEngine https://t.co/YbwrWEbp91
July 19th 2017, 12:07am
investpro2000 @investpro2000
RT @investpro2000: $BMRN BUYOUT SOON BioMarin's gene therapy for hemophilia A shows durable treatment effect in mid-stage study https://t.c…
July 18th 2017, 10:07pm
investpro2000 @investpro2000
RT @tgtxdough: Cowen $BMRN BMN270 Appears Capable Of Changing Hemophilia Treatment Paradigm,Though Wide Interpatient Variability In Factor…
July 18th 2017, 10:07pm
MFFAIS @MFFAIS
$bmrn down -4.6% in one day Palo Alto Investors Llc saved 2086K. What else do they know? #investing #stocks https://t.co/2JFPasF3ph
July 18th 2017, 7:07pm
TheMarketsDaily @TheMarketsDaily
Analysts Anticipate BioMarin Pharmaceutical Inc. $BMRN Will Announce Earnings of -$0.19 Per Share https://t.co/G5EFxpAuxP
July 18th 2017, 7:07pm
WKRBNews @WKRBNews
Analysts Anticipate BioMarin Pharmaceutical Inc. $BMRN Will Announce Earnings of -$0.19 Per Share https://t.co/XqvV1H6why
July 18th 2017, 7:07pm
WKRBNews @WKRBNews
Analysts Anticipate BioMarin Pharmaceutical Inc. $BMRN Will Announce Earnings of -$0.19 Per Share https://t.co/yGgbdFBhES
July 18th 2017, 7:07pm
intercooleronli @intercooleronli
BioMarin Pharmaceutical Inc. $BMRN Receives “Buy” Rating from Leerink Swann https://t.co/g4t5UT8tzB
July 18th 2017, 6:07pm
TPCMG @TPCMG
$BMRN: 3 open, suited signals indicate continued price decrease for about 3 more days. https://t.co/B3q6h9smAE
July 18th 2017, 6:07pm
AceOfSpades2007 @AceOfSpades2007
$SRPT had a place of power to negotiate. $BMRN couldn't file injunction to halt sales. It would've been political suicide.+ no working drug
July 18th 2017, 6:07pm
IRAMarketReport @IRAMarketReport
BioMarin Pharmaceutical Inc. $BMRN Earns Buy Rating from SunTrust Banks, Inc. https://t.co/YMpVqNWtWZ
July 18th 2017, 6:07pm
AceOfSpades2007 @AceOfSpades2007
Not agreeing that the patent deal's positive for $SRPT. 1) I maintain they would've won 2) $BMRN gets 5&8% US&EU SALES. Not profit but sales
July 18th 2017, 6:07pm
chaffeybreeze @chaffeybreeze
BioMarin Pharmaceutical Inc. $BMRN Earns Buy Rating from SunTrust Banks, Inc. https://t.co/Puy8dMsGOA
July 18th 2017, 6:07pm
investpro2000 @investpro2000
RT @odibro: $SRPT $BMRN Announce Execution of a Global Settlement & License Agreement Resolving Exon Skipping Patent Litigation https://t.c…
July 18th 2017, 5:07pm
chaffeybreeze @chaffeybreeze
BioMarin Pharmaceutical Inc. $BMRN Stock Rating Reaffirmed by Leerink Swann https://t.co/frUSVUpj2Z
July 18th 2017, 3:07pm
IRAMarketReport @IRAMarketReport
BioMarin Pharmaceutical Inc. $BMRN Stock Rating Reaffirmed by Leerink Swann https://t.co/lzVx92kdWN
July 18th 2017, 3:07pm
dhovekamp42 @dhovekamp42
RT @bio_clouseau: More details on $SRPT $BMRN settlement https://t.co/uf4NXHQSkN
July 18th 2017, 2:07pm
DrEdGd @DrEdGd
RT @adamfeuerstein: $SRPT and $BMRN... https://t.co/UgT0K0wSlL
July 18th 2017, 2:07pm
DrEdGd @DrEdGd
RT @zbiotech: $SRPT $BMRN enter global settlement agreement for exon-skipping products
July 18th 2017, 2:07pm
biopharmacaster @biopharmacaster
$bmrn should be green, a little confused, was trading at 91+ yesterday
July 18th 2017, 2:07pm
newswelldone @newswelldone
$SRPT $BMRN: BioMarin snags cash as Sarepta skips Duchenne patent battle: https://t.co/lNuMXwYWVw
July 18th 2017, 1:07pm
vlad33301 @vlad33301
@MauriceOnTW Mostly speculating but based on skimming through some $BMRN patent applications that reference Rep 78 and 52
July 18th 2017, 12:07pm
TheMarketsDaily @TheMarketsDaily
SunTrust Banks, Inc. Reiterates “Buy” Rating for BioMarin Pharmaceutical Inc. $BMRN https://t.co/7uUuclB0gT
July 18th 2017, 9:07am
greyzone513 @greyzone513
RT @DrPhobius: I feel IP royalties paid to $BMRN by $SRPT is on the high side. 8% for EU and RoW (should have been 5%), and 5% for US (shou…
July 18th 2017, 9:07am
Hall8Jack @Hall8Jack
@DrPhobius math still doesnt add up, esp when u consider pot. next gen DMD therapies such as GeneTx, PPMO, Utrophin, Myostatin $srpt $bmrn
July 18th 2017, 9:07am
investpro2000 @investpro2000
Sarepta and BioMarin settle exon skipping patent fight $SRPT $BMRN https://t.co/8sUKYh35qx
July 18th 2017, 9:07am
JSTOCKBROKERS @JSTOCKBROKERS
RT @GantosJ: $SRPT & $BMRN Settlement resolving Exon Skipping IP litigation reminds me of ED interview with Bloomberg, said: “We are goin…
July 18th 2017, 9:07am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.